Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
sevelamer carbonate sevelamer · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | OTHER | sevelamer carbonate powder x 4 weeks then, sevelamer hydrochloride x 4 weeks |
| 2 | OTHER | sevelamer hydrochloride x 4 weeks then, sevelamer carbonate powder x 4 weeks |
| Name | Type | Description |
|---|---|---|
| sevelamer carbonate (Renvela®) sevelamer hydrochloride (Renagel ®) | DRUG | sevelamer carbonate powder dosed TID with meals for four weeks followed by sevelamer hydrochloride tablets dosed TID with meals for four weeks |
| sevelamer hydrochloride (Renagel ®) sevelamer carbonate (Renvela®) | DRUG | sevelamer hydrochloride tablets dosed TID with meals for four weeks followed by sevelamer carbonate powder dosed TID with meals for four weeks |
Inclusion Criteria: * Receiving three times per week haemodialysis for three months or longer. * Taking sevelamer hydrochloride alone (e.g. not using other types of phosphate binders concomitantly) or on combination therapy (e.g. using sevelamer hydrochloride and calcium containing, or metal phosph...
Top 20 of 25 competitors